(17.) INCOME TAXES

The income tax expense (benefit) for the years ended December 31 consisted of the following (in thousands):

 

 

2025

 

 

2024

 

 

2023

 

Current tax expense (benefit):

 

 

 

 

 

 

 

 

 

Federal

 

$

5,641

 

 

$

9,031

 

 

$

13,302

 

State

 

 

(699

)

 

 

(185

)

 

 

835

 

Total current tax expense

 

 

4,942

 

 

 

8,846

 

 

 

14,137

 

Deferred tax expense (benefit):

 

 

 

 

 

 

 

 

 

Federal

 

 

8,950

 

 

 

(26,987

)

 

 

(1,136

)

State

 

 

2,595

 

 

 

(8,361

)

 

 

(212

)

Total deferred tax expense (benefit)

 

 

11,545

 

 

 

(35,348

)

 

 

(1,348

)

Total income tax expense (benefit)

 

$

16,487

 

 

$

(26,502

)

 

$

12,789

 

 

The effective income tax rate differed from the U.S. federal statutory income tax rate for the years ended December 31 due to the following (dollars in thousands):

 

 

2025

 

 

 

Amount

 

 

Percent

 

Income before provision for income taxes

 

$

91,354

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit) at U.S. federal statutory rate

 

 

19,184

 

 

 

21.00

%

State and local income tax, net of federal income tax effect (1)

 

 

1,498

 

 

 

1.64

 

Tax credits:

 

 

 

 

 

 

Low-income housing tax credits

 

 

(2,140

)

 

 

(2.24

)

Historic tax credits

 

 

(1,903

)

 

 

(2.21

)

Nontaxable and nondeductible items

 

 

 

 

 

 

Company owned life insurance - Cash surrender value/premium

 

 

(2,366

)

 

 

(2.59

)

Company owned life insurance - Surrender gain & MEC penalty

 

 

2,634

 

 

 

2.88

 

Other nontaxable and nondeductible items

 

 

(45

)

 

 

(0.05

)

Other adjustments

 

 

(375

)

 

 

(0.38

)

Total

 

$

16,487

 

 

 

18.05

%

 

(1)
State taxes in New York made up the majority of the effect of the state and local tax category.

 

 

 

2024

 

 

2023

 

Federal statutory income tax

 

 

(21.0

%)

 

 

21.0

%

Increase (decrease) resulting from:

 

 

 

 

 

 

Tax exempt interest income

 

 

(0.6

)

 

 

(0.8

)

Tax credits and adjustments

 

 

(6.4

)

 

 

(2.1

)

Net non-taxable earnings on company owned life insurance

 

 

(1.7

)

 

 

0.9

 

State taxes, net of federal tax benefit

 

 

(9.9

)

 

 

0.8

 

Other, net

 

 

0.7

 

 

 

0.5

 

Total

 

 

(38.9

%)

 

 

20.3

%

 

Total income tax expense (benefit) was as follows for the years ended December 31 (in thousands):

 

 

 

2025

 

 

2024

 

 

2023

 

Income tax expense (benefit)

 

$

16,487

 

 

$

(26,502

)

 

$

12,789

 

Shareholders’ equity

 

 

6,743

 

 

 

23,196

 

 

 

6,044

 

 

(17.) INCOME TAXES (Continued)

The Company recognizes deferred income taxes for the estimated future tax effects of differences between the tax and financial statement bases of assets and liabilities considering enacted tax laws. These differences result in deferred tax assets and liabilities, which are included in other assets in the Company’s consolidated statements of financial condition. The Company also assesses the likelihood that deferred tax assets will be realizable based on, among other considerations, future taxable income and establishes, if necessary, a valuation allowance for those deferred tax assets determined to not likely be realizable. A deferred tax asset valuation allowance is recognized if, based on the weight of available evidence (both positive and negative), it is more likely than not that some portion or all of the deferred tax assets will not be realized. The future realization of deferred tax benefits depends upon the existence of sufficient taxable income within the carry-back and carry-forward periods. Management’s judgment is required in determining the appropriate recognition of deferred tax assets and liabilities, including projections of future taxable income.

Based upon the Company’s historical and projected future levels of pre-tax and taxable income, the scheduled reversals of taxable temporary differences to offset future deductible amounts, and prudent and feasible tax planning strategies, management believes it is more likely than not that the deferred tax assets will be realized. Therefore, no valuation allowance has been recorded as of December 31, 2025 and 2024.

In 2025 and 2024, the Company recognized the impact of its investments in limited partnerships and limited liability companies that generated qualifying tax credits resulting in a $4.5 million and $4.6 million reduction in income tax expense, respectively, and a $2.0 million and $775 thousand net loss recorded in noninterest income, respectively. See Note 1, Summary of Significant Accounting Policies, for the Company’s accounting policy for income taxes and these tax credit investments.

The Company’s net deferred tax asset is included in other assets in the consolidated statements of financial condition. The tax effects of temporary differences that give rise to the deferred tax assets and deferred tax liabilities are as follows at December 31 (in thousands):

 

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Allowance for credit losses

 

$

13,550

 

 

$

13,362

 

Leases–right of use obligations

 

 

8,047

 

 

 

8,351

 

Deferred compensation

 

 

1,689

 

 

 

1,168

 

Investments in limited partnerships

 

 

1,069

 

 

 

1,369

 

SERP agreements

 

 

25

 

 

 

45

 

Litigation settlement reserve

 

 

-

 

 

 

5,899

 

Share-based compensation

 

 

1,070

 

 

 

793

 

Tax attribute carryforward benefit

 

 

20,039

 

 

 

28,116

 

Net unrealized loss on securities available for sale

 

 

9,164

 

 

 

15,823

 

Accrued pension costs

 

 

389

 

 

 

463

 

Deferred loan origination costs

 

 

862

 

 

 

178

 

Other

 

 

1,424

 

 

 

1,219

 

Gross deferred tax assets

 

 

57,328

 

 

 

76,786

 

Deferred tax liabilities:

 

 

 

 

 

 

Leases–right of use assets

 

 

7,404

 

 

 

7,738

 

Prepaid expenses

 

 

859

 

 

 

1,015

 

Intangible assets

 

 

2,778

 

 

 

2,523

 

Depreciation and amortization

 

 

2,779

 

 

 

3,153

 

Loan servicing assets

 

 

453

 

 

 

409

 

Other

 

 

458

 

 

 

1,063

 

Gross deferred tax liabilities

 

 

14,731

 

 

 

15,901

 

Net deferred tax asset

 

$

42,597

 

 

$

60,885

 

The Company and its subsidiaries are primarily subject to federal and New York income taxes. The federal income tax years currently open for audit are 2022 through 2025. The New York income tax years currently open for audit are 2022 through 2025.

At December 31, 2025, the Company had tax attribute carryforward benefits totaling $20.0 million for federal and New York net operating losses and tax credit carryforwards generated in the fourth quarter of 2024, primarily due to the realized losses from the investment security repositioning. At December 31, 2025, the Company had a federal credit carryforward of $15.9 million that expires in 2044, and a New York net operating loss carryforward of $88.5 million that expires in 2044.

(17.) INCOME TAXES (Continued)

The Company’s unrecognized tax benefits and changes in unrecognized tax benefits were not significant as of or for the years ended December 31, 2025, 2024 and 2023. There were no material interest or penalties recorded in the income statement in income tax expense for the years ended December 31, 2025, 2024 and 2023. As of December 31, 2025 and 2024, there were no amounts accrued for interest or penalties related to uncertain tax positions.

During 2025, the Company made no income tax payments and received a refund of $17 thousand from New York.

Historical Timeline

Fiscal YearFiled
2025Mar 9, 2026Showing above
2024Mar 12, 2025
2023Mar 13, 2024
2022Mar 9, 2023
2021Mar 10, 2022
2020Mar 15, 2021
2019Mar 4, 2020
2018Mar 8, 2019
2017Mar 14, 2018
2016Mar 7, 2017
2015Mar 8, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.